AGL 24.24 Increased By ▲ 0.77 (3.28%)
AIRLINK 107.70 Increased By ▲ 1.59 (1.5%)
BOP 5.12 Decreased By ▼ -0.05 (-0.97%)
CNERGY 3.63 Decreased By ▼ -0.03 (-0.82%)
DCL 7.32 Decreased By ▼ -0.48 (-6.15%)
DFML 42.10 Decreased By ▼ -2.09 (-4.73%)
DGKC 88.80 Increased By ▲ 0.30 (0.34%)
FCCL 21.75 No Change ▼ 0.00 (0%)
FFBL 41.85 Decreased By ▼ -0.67 (-1.58%)
FFL 8.61 Decreased By ▼ -0.14 (-1.6%)
HUBC 148.75 Increased By ▲ 0.95 (0.64%)
HUMNL 10.14 Decreased By ▼ -0.11 (-1.07%)
KEL 4.28 Decreased By ▼ -0.06 (-1.38%)
KOSM 3.59 Decreased By ▼ -0.20 (-5.28%)
MLCF 36.20 Decreased By ▼ -0.20 (-0.55%)
NBP 47.75 Decreased By ▼ -1.55 (-3.14%)
OGDC 129.10 Decreased By ▼ -1.75 (-1.34%)
PAEL 25.75 Decreased By ▼ -0.20 (-0.77%)
PIBTL 6.00 Decreased By ▼ -0.05 (-0.83%)
PPL 113.65 Decreased By ▼ -0.90 (-0.79%)
PRL 22.30 Decreased By ▼ -0.30 (-1.33%)
PTC 12.10 Decreased By ▼ -0.27 (-2.18%)
SEARL 54.98 Decreased By ▼ -0.72 (-1.29%)
TELE 7.11 Decreased By ▼ -0.14 (-1.93%)
TOMCL 37.11 Increased By ▲ 0.71 (1.95%)
TPLP 7.76 Decreased By ▼ -0.19 (-2.39%)
TREET 15.00 Decreased By ▼ -0.29 (-1.9%)
TRG 55.54 Decreased By ▼ -1.16 (-2.05%)
UNITY 31.20 Decreased By ▼ -0.65 (-2.04%)
WTL 1.15 Decreased By ▼ -0.02 (-1.71%)
BR100 8,248 Decreased By -46.7 (-0.56%)
BR30 25,878 Decreased By -223.8 (-0.86%)
KSE100 78,030 Decreased By -439.8 (-0.56%)
KSE30 25,084 Decreased By -114.2 (-0.45%)
Markets

European stocks end lower on virus, policy jitters

  • German consumer morale darkens: GfK
  • Travel stocks fall on virus woes
  • Swedish Orphan Biovitrum tops STOXX 600
Published August 26, 2021

European shares ended lower on Thursday after data showed faltering German consumer morale amid rising COVID-19 cases, while investors fretted over US monetary policy ahead of the Jackson Hole symposium.

The pan-European STOXX 600 index fell 0.3%, with mining and travel & leisure stocks leading losses.

The STOXX 600 had briefly deepened its losses towards the close, tracking a fall in US stocks after sentiment was rattled by a blast in Kabul.

Anticipation of the US Federal Reserve's annual Jackson Hole summit on Friday kept investors on their toes, with chair Jerome Powell's speech likely to offer hints on the central bank's plans to taper its massive stimulus programme.

"We think that those expecting clear communication about the shape and timing of the tapering of asset purchases may be disappointed," said Paolo Zanghieri, senior economist at Generali Investments. "The recent data remain strong, but momentum is receding and inflation fears have not surged."

Blast outside Kabul airport kills at least 13, including children: Taliban official

A survey showed the mood among German consumers darkened heading into September as accelerating inflation and rising COVID-19 cases made them more hesitant to buy.

Business morale in the euro zone's largest economy fell for the second month running in August, data on Wednesday showed.

"Risks are tilted to the downside over the near term," analysts at BCA Research said. "While global COVID-19 cases appear to be rolling over and (China's) Ningbo-Zhoushan port has reopened, which are both positive for supply chains, COVID-19 cases are still climbing in Germany."

European travel company Tui, airlines Wizz Air , Lufthansa and British Airways-owner IAG fell by between 0.9% and 3.8%.

Wizz Air was the worst performer on the STOXX 600, dropping 3.8%.

Germany's blue-chip DAX dropped 0.4%, marking its lowest closing level in a week, while the UK's FTSE 100 and France's CAC 40 declined by 0.4% and 0.2%, respectively.

Deutsche Bank's asset management arm DWS Group fell 13.7% on a report US authorities were investigating DWS over sustainability claims. Deutsche Bank's shares dropped 1.5%.

France's Vivendi rose 2.6% after its unit Universal Music Group said it expects further revenue growth this year and it aims to pay out dividends once it lists in Amsterdam.

French conglomerate Bouygues gained 1.1% as it raised its full-year earnings outlook.

Swedish Orphan Biovitrum was the best performer on the STOXX 600, rising 8.8% after Bloomberg reported that private equity firm Advent International is considering a bid for the pharmaceutical maker.

Comments

Comments are closed.